SUPRA SDRM®
Deep partial-thickness burns, chronic wounds (e.g., venous leg ulcers)
ApprovedActive
Key Facts
Indication
Deep partial-thickness burns, chronic wounds (e.g., venous leg ulcers)
Phase
Approved
Status
Active
Company
About PolyMedics Innovation
PolyMedics Innovation is a commercial-stage medtech company focused on revolutionizing wound care through its synthetic skin substitutes. Its core technology, SUPRA EPT™ (Engineered Polylactide Technology), enables the creation of biodegradable, absorbable membranes and matrices that avoid the biological risks associated with animal- or human-derived products. With its flagship products SUPRATHEL® and SUPRA SDRM® distributed in over 40 countries and used on more than 250,000 patients, PMI is established as a leader in the shift towards synthetic wound healing solutions. The company leverages a strong clinical evidence base from numerous trials to drive adoption.
View full company profile